COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,310 Articles (22,772 medRxiv, 8,538 bioRxiv)

Most recent first Previous |  Page 211: Articles 2101-2110  | Next

Dominant induction of the inflammasome by the SARS-CoV-2 accessory protein ORF9b, abrogated by small-molecule ORF9b homodimerization inhibitors
Zodda, E., Pons, M., DeMoya-Valenzuela, N., Calvo-Gonzalez, C., Benitez-Rodriguez, C., Lopez-Ayllon, B. D., Hibot, A., Cascante, M., Montoya, M., Pujol, M., Rubio-Martinez, J., Thomson, T. M.
10.1101/2024.05.31.596900 — Posted: 2024-06-03
Respiratory mucosal administration of DNA aptamer nanomaterials protects against antigenically diverse SARS-CoV-2 variants
D'Agostino, M. R., Li, J., Zhang, Z., Gu, J., Marzok, A., Ang, J., Bujold, K. E., Afkhami, S., Xia, X., Li, Y., Miller, M. S.
10.1101/2024.05.31.596896 — Posted: 2024-06-03
A predominately pulmonary activation of complement in a mouse model of severe COVID-19
Szachowicz, P. J., Wohlford-Lenane, C. L., Heinen, C. J., Ghimire, S., Xue, B., Boly, T. J., Verma, A. K., Masinovic, L., Bermick, J. R., Perlman, S., Meyerholz, D. K. J., Pezzulo, A. A. A., Zhang, Y., Smith, R. J. H., McCray, P. B.
10.1101/2024.05.31.596892 — Posted: 2024-06-03
Urban wastewater contains a functional human antibody repertoire of mucosal origin
Stephenson, S., Eid, W., Wong, C. H., Mercier, E., D'Aoust, P. M., Kabir, M. P., Baral, S., Gilbride, K. A., Oswald, C., Straus, S. E., Mackenzie, A., Delatolla, R., Graber, T. E.
10.1101/2024.06.02.597066 — Posted: 2024-06-03
Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections
Wang, Z., Li, L., Du, R., Chen, X., Sun, Y., Qin, R., Li, Y., Feng, H., Hu, L., Chen, X., Lu, M., Jiang, L., Zuo, T.
10.1101/2024.05.30.596664 — Posted: 2024-06-02
ACUTE KIDNEY INJURY AS A PREDICTOR OF IN-HOSPITAL MORTALITY IN PATIENTS WITH A DIAGNOSIS OF SEVERE COVID-19
Cruz Ordinola, A., Fajardo Arriola, C., Sandoval Ato, R.
10.1101/2024.05.31.24308297 — Posted: 2024-06-01
Within-host dynamics of antiviral treatment for SARS-CoV-2 infection
Schuh, L., Markov, P. V., Voulgaridi, I., Bogogiannidou, Z., Mouchtouri, V. A., Hadjichristodoulou, C., Stilianakis, N. I.
10.1101/2024.05.31.24308284 — Posted: 2024-06-01
Assessing Excess Mortality Patterns in Argentina over the COVID-19 Pandemic (2020-2021): A Comprehensive National and Subnational Analysis
Pennini, V., Santoro, A., Esteban, S., Volij, C., Rubinstein, A.
10.1101/2024.05.31.24308276 — Posted: 2024-06-01
Medical Costs, Health Care Utilization, and Productivity Losses Associated With Hypertension by COVID-19 Among US Commercial Enrollees
Lee, J. S., Zhang, Y., Wang, Y., Park, J., Kumar, A., Donald, B., Luo, F., Roy, K.
10.1101/2024.05.31.24308307 — Posted: 2024-06-01
Impact of rotavirus vaccination in Malawi from 2012 to 2022 compared to model predictions before, during, and after the COVID-19 pandemic
Pitzer, V. E., Ndeketa, L., Asare, E. O., Hungerford, D., Jere, K. C., Cunliffe, N. A.
10.1101/2024.05.29.24308124 — Posted: 2024-05-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).